Press Releases (-) Any 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2020 May 26, 2020 argenx Announces Positive Topline Phase 3 ADAPT Trial Results May 14, 2020 argenx reports first quarter 2020 financial results and provides business update May 12, 2020 argenx announces results of Annual General Meeting of Shareholders May 8, 2020 argenx to Present Data from Phase 2 Trial of Efgartigimod in Pemphigus at 2020 Society for Investigative Dermatology (SID) Virtual Annual Meeting May 7, 2020 argenx to report first quarter 2020 financial results and business update on May 14, 2020 May 5, 2020 argenx to Present at BofA Securities Virtual Health Care Conference 2020 March 31, 2020 argenx announces Annual General Meeting of Shareholders on May 12, 2020 February 26, 2020 argenx full year 2019 financial results February 24, 2020 argenx to Present at Cowen 40th Annual Health Care Conference February 19, 2020 argenx to report full year 2019 financial results and fourth quarter business update on February 27, 2020 January 8, 2020 argenx Provides Strategic Outlook Advancing Late-Stage Pipeline Towards ‘argenx 2021’ Vision 2019 March 12, 2020 argenx announces publication of efgartigimod Phase 2 primary immune thrombocytopenia trial results in American Journal of Hematology Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
